Neuropharmacology and Neurochemistry

Neuropharmacology refers to the study of the effects of drugs on the nervous system, this field involve the study and research on the actions of medications for psychiatric and neurologic disorders as well as those of drugs of abuse. Neuropharmacology also uses drugs as tools for better understanding of normal nervous system functioning. The main objective of neuropharmacology is to apply mechanisms of drugs to develop effective treatments and preventive measures for nervous system abnormalities. It helps to understand how drugs affect cellular function in the nervous system. Behavioral and molecular are the two different parts of neuropharmacology . Behavioral neuropharmacology focuses on the study of how drugs affect human behavior and molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with an aim of developing drugs that helps in improving neurological function.

The study of  neurotransmitters, psychopharmaceuticals and neuropeptides, that control and influence the physiology of the nervous system is known as Neurochemistry. Research in this field is focused on the biochemistry and molecular biology of organic compounds in the nervous system, and their roles in neural processes like cortical plasticity, neurogenesis, and neural differentiation. Neurochemicals are basically oxytocin, serotonin, dopamine and other neurotransmitters and neurotransmitter-regulating substances. This particular field investigates how neurochemicals influence the operation of neurons, synapses, and neural networks. 

Market Analysis: Pharmaceuticals are one of the most valuable endeavours on the planet. In 2008, the pharmaceutical industry sold $773 billion in goods around the world, a figure that has been consistent for up to 8 years and is expected to rise by 2.5 to 3.5 percent in 2017. By 2025, the global pharmaceutical market is expected to reach $10.27 billion USD. The pharmaceutical market is expected to grow from just over $22.85 billion in 2016 to $25.2 billion in 2020, with a compound annual growth rate (CAGR) of 2%. It is expected to reach USD 2,151.1 billion by 2027, growing at a CAGR of 7%.


Stroke Conferences Neurology Conferences 2022 Japan Neurology Conferences 2022 Europe Neurology Conferences USA Headache Conferences Psychology Conferences Alzheimer's Disease Conferences Parkinson Disease Conferences Neurodegenerative Disorders Conferences Neurology Conferences 2022 USA Euro Neurology Conferences Sleep Disorders Conferences Neurology Conferences 2022 Child Psychology Conferences Brain Cancer Conferences